[1] Umanath K, Lewis JB.Update on diabetic nephropathy: core curriculum 2018[J].Am J Kidney Dis, 2018, 71(6): 884-895. [2] Sun H, Saeedi P, Karuranga S, et al.IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J].Diabetes Res Clin Pract, 2022, 183(1): 119-125. [3] Selby NM, Taal MW.An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines[J].Diabetes Obes Metab, 2020, 22(Suppl.1): 13-15. [4] Doshi SM, Friedman AN.Diagnosis and management of type 2 diabetic kidney disease[J].Clin J Am Soc Nephrol, 2017, 12(8): 1366-1373. [5] 贺小宁, 张雅雯, 阮贞, 等.中国2型糖尿病患者慢性并发症患病率与次均医疗费用研究[J].中华内分泌代谢杂志, 2019, 35(3): 200-205. [6] Chen, C. CiteSpaceⅡ: Detecting and visualizing emerging trends and transient patterns in scientific literature[J].J Am Soc Inf Sci Technol, 2006, 57(3): 359-377. [7] Van Dieren S, Beulens JW, Vander Schouw YT, et al.The global burden of diabetes and its complications: an emerging pandemic[J].Eur J Cardiovasc Prev Rehabil, 2010, 17(Suppl.1): S3-S8. [8] Mann JFE, Orsted DD, Buse JB.Liraglutide and renal outcomes in type 2 diabetes[J].N Engl J Med, 2017, 377(22): 2197-2198. [9] Tuttle KR, Bakris GL, Bilous RW, et al.Diabetic kidney disease: a report from an ADA Consensus Conference[J].Diabetes Care, 2014, 37(10): 2864-2883. [10] Groop PH, Thomas MC, Moran JL, et al.The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes[J].Diabetes, 2009, 58 (7): 1651-1658. [11] Haroun MK, Jaar BG, Hoffman SC, et al.Risk factors for chronic kidney disease: a prospective study of 23, 534 men and women in Washington County, Mary land[J].J Am Soc Nephrol, 2003, 14(11): 2934-2941. [12] Kim YC, Shin N, Lee S, et al.Effect of post-transplant glycemic control on long-term clinical outcomes in kidney transplant recipients with diabetic nephropathy: A multicenter cohort study in Korea[J].PLoS One, 2018, 13(4): e0195566. [13] Nanwani B, Shankar P, Kumar R, et al.Risk factors of diabetic foot amputation in pakistani type II diabetes individuals[J].Cureus, 2019, 11(6): e4795. [14] Ahola AJ, Harjutsalo V, Forsblom C, et al.Depression is associated with progression of diabetic nephropathy in type 1 diabetes[J].Diabetes Care, 2021, 44(1): 174-180. [15] Gebre BB, Anand S, Assefa ZM.Depression and its predictors among diabetes mellitus patients attending treatment in hawassa university comprehensive specialized hospital, southern ethiopia[J].J Diabetes Res, 2020, 22(2): e7138513. [16] 中华医学会肾脏病学分会专家组.糖尿病肾脏疾病临床诊疗中国指南[J].中华肾脏病杂志, 2021, 37(2): 255-304. [17] Kravets I, Mallipattu SK.The role of podocytes and podocyte-associated biomarkers in diagnosis and treatment of diabetic kidney disease[J].J Endocr Soc, 2020, 4(4): bvaa029. [18] Kawaguchi H, Moriyama M, Hashimoto H.Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysis[J].BMC Health Serv Res, 2020, 20(1): 403. [19] Lewinski AA, Patel UD, Diamantidis CJ, et al.Addressing diabetes and poorly controlled hypertension: pragmatic mHealth self-management intervention[J].J Med Internet Res, 2019, 21(4): e12541. |